Retracted: In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer

Open Access
Publisher Website
Google Scholar
Abstract
This article has been retracted at the request of: Editor‐in‐Chief and Author ‘In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer’ by Banerjee, S., Zhang, Y., Wang, Z., Che, M., Chiao, P. J., Abbruzzese, J. L. and Sarkar, F. H. The above article and associated erratum, published online on 27 November 2006 and 6 February 2014, respectively, in Wiley Online Library (wileyonlinelibrary.com), have been retracted by agreement between the authors, the journal Editor‐in‐Chief, Professor Peter Lichter, and Wiley Periodicals, Inc. A university investigation involving the first and the corresponding author determined that several figures in this paper, including the b‐actin bands in Fig. 1C in the erratum, were re‐used, mislabeled, manipulated, or duplicated while processing/compiling the final figures assembled from the original data sources. Therefore, the authors are retracting the paper in its entirety although they maintain that these issues did not affect the major conclusions. They apologize for any inconvenience this may have caused. ReferenceBanerjee, S., Zhang, Y., Wang, Z., Che, M., Chiao, P. J., Abbruzzese, J. L. and Sarkar, F. H. (2007), In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int. J. Cancer, 120: 906–917. doi: 10.1002/ijc.22332; corrected by Erratum: In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int. J. Cancer, 134: E4. doi: 10.1002/ijc.28710.
Funding Information
  • National Cancer Institute NIH (1R01CA101870-03)
  • University of Texas MD Anderson Cancer Center (SP20CA 101936-04)